Overview

Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan

Status:
Withdrawn
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study will assess how rifampin will affect the blood levels of sitaxsentan. Safety of sitaxsentan given alone and with rifampin will also be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Rifampin
Sitaxsentan